DD279687A5 - Verfahren zur herstellung von erythropoietin - Google Patents

Verfahren zur herstellung von erythropoietin Download PDF

Info

Publication number: DD279687A5
Authority: DD; German Democratic Republic
Prior art keywords: epo; cells; dna; fragment; plasmid
Prior art date: 1985-01-22

Application number

DD87310862A

Other languages

German (de)

English (en)

Inventor

Edward Fritsch

Rodney M Hewick

Kenneth Jacobs

Randal J Kaufmann

Original Assignee

Genetics Institute Inc.,Us

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-01-22

Filing date

1987-12-06

Publication date

1990-06-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24783958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD279687(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-12-06 Application filed by Genetics Institute Inc.,Us filed Critical Genetics Institute Inc.,Us

1990-06-13 Publication of DD279687A5 publication Critical patent/DD279687A5/de

Links

OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title claims abstract description 154
238000000034 method Methods 0.000 title claims abstract description 52
238000004519 manufacturing process Methods 0.000 title claims abstract description 20
102000003951 Erythropoietin Human genes 0.000 title claims abstract description 16
108090000394 Erythropoietin Proteins 0.000 title claims abstract description 16
229940105423 erythropoietin Drugs 0.000 title claims abstract description 15
230000008569 process Effects 0.000 title claims abstract description 7
230000014509 gene expression Effects 0.000 claims abstract description 31
108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 13
210000004027 cell Anatomy 0.000 claims description 83
108020004414 DNA Proteins 0.000 claims description 38
239000013598 vector Substances 0.000 claims description 33
210000004962 mammalian cell Anatomy 0.000 claims description 8
241000701822 Bovine papillomavirus Species 0.000 claims description 4
241000699802 Cricetulus griseus Species 0.000 claims description 3
230000002611 ovarian Effects 0.000 claims 1
239000003814 drug Substances 0.000 abstract description 5
238000012258 culturing Methods 0.000 abstract description 2
108010092408 Eosinophil Peroxidase Proteins 0.000 description 148
102100031939 Erythropoietin Human genes 0.000 description 144
239000012634 fragment Substances 0.000 description 88
239000013612 plasmid Substances 0.000 description 68
108090000623 proteins and genes Proteins 0.000 description 68
239000002299 complementary DNA Substances 0.000 description 28
235000018102 proteins Nutrition 0.000 description 27
102000004169 proteins and genes Human genes 0.000 description 27
239000002609 medium Substances 0.000 description 25
239000002773 nucleotide Substances 0.000 description 22
101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 20
101150002621 EPO gene Proteins 0.000 description 19
125000003729 nucleotide group Chemical group 0.000 description 19
241000700605 Viruses Species 0.000 description 15
125000003275 alpha amino acid group Chemical group 0.000 description 15
210000004978 chinese hamster ovary cell Anatomy 0.000 description 15
239000000523 sample Substances 0.000 description 15
238000000338 in vitro Methods 0.000 description 14
230000001605 fetal effect Effects 0.000 description 13
238000009396 hybridization Methods 0.000 description 13
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 12
230000029087 digestion Effects 0.000 description 12
210000004185 liver Anatomy 0.000 description 12
229960000485 methotrexate Drugs 0.000 description 12
241000701161 unidentified adenovirus Species 0.000 description 12
241000238631 Hexapoda Species 0.000 description 11
108020004999 messenger RNA Proteins 0.000 description 11
101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 10
101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 10
238000003127 radioimmunoassay Methods 0.000 description 10
238000012216 screening Methods 0.000 description 10
150000001413 amino acids Chemical class 0.000 description 9
239000000499 gel Substances 0.000 description 9
102000044890 human EPO Human genes 0.000 description 9
210000002700 urine Anatomy 0.000 description 9
108091026890 Coding region Proteins 0.000 description 8
108091034117 Oligonucleotide Proteins 0.000 description 8
235000001014 amino acid Nutrition 0.000 description 8
230000010076 replication Effects 0.000 description 8
239000000243 solution Substances 0.000 description 8
101710182846 Polyhedrin Proteins 0.000 description 7
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
230000000694 effects Effects 0.000 description 7
210000003743 erythrocyte Anatomy 0.000 description 7
238000002955 isolation Methods 0.000 description 7
239000000203 mixture Substances 0.000 description 7
239000000047 product Substances 0.000 description 7
102000004594 DNA Polymerase I Human genes 0.000 description 6
108010017826 DNA Polymerase I Proteins 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
108010022394 Threonine synthase Proteins 0.000 description 6
238000010276 construction Methods 0.000 description 6
102000004419 dihydrofolate reductase Human genes 0.000 description 6
238000000746 purification Methods 0.000 description 6
238000004007 reversed phase HPLC Methods 0.000 description 6
238000001890 transfection Methods 0.000 description 6
208000032467 Aplastic anaemia Diseases 0.000 description 5
108700024394 Exon Proteins 0.000 description 5
239000004480 active ingredient Substances 0.000 description 5
239000003623 enhancer Substances 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
238000005304 joining Methods 0.000 description 5
239000012528 membrane Substances 0.000 description 5
229920002401 polyacrylamide Polymers 0.000 description 5
230000008488 polyadenylation Effects 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
238000012546 transfer Methods 0.000 description 5
241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 4
241000701109 Human adenovirus 2 Species 0.000 description 4
108020005187 Oligonucleotide Probes Proteins 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
229920002367 Polyisobutene Polymers 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 4
108090000631 Trypsin Proteins 0.000 description 4
208000007502 anemia Diseases 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000004071 biological effect Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
239000003636 conditioned culture medium Substances 0.000 description 4
238000001514 detection method Methods 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000001502 gel electrophoresis Methods 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
210000004940 nucleus Anatomy 0.000 description 4
239000002751 oligonucleotide probe Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
230000009466 transformation Effects 0.000 description 4
239000012588 trypsin Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 3
102000012410 DNA Ligases Human genes 0.000 description 3
108010061982 DNA Ligases Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
206010021143 Hypoxia Diseases 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
108090000157 Metallothionein Proteins 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
241000700159 Rattus Species 0.000 description 3
239000004098 Tetracycline Substances 0.000 description 3
239000000872 buffer Substances 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
239000012228 culture supernatant Substances 0.000 description 3
239000012894 fetal calf serum Substances 0.000 description 3
230000012010 growth Effects 0.000 description 3
238000003306 harvesting Methods 0.000 description 3
230000001146 hypoxic effect Effects 0.000 description 3
210000001672 ovary Anatomy 0.000 description 3
239000002243 precursor Substances 0.000 description 3
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
229960002180 tetracycline Drugs 0.000 description 3
229930101283 tetracycline Natural products 0.000 description 3
235000019364 tetracycline Nutrition 0.000 description 3
150000003522 tetracyclines Chemical class 0.000 description 3
229940124597 therapeutic agent Drugs 0.000 description 3
238000000108 ultra-filtration Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
241000701959 Escherichia virus Lambda Species 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
101100333654 Homo sapiens EPO gene Proteins 0.000 description 2
101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
102000003792 Metallothionein Human genes 0.000 description 2
241001529936 Murinae Species 0.000 description 2
241001460678 Napo <wasp> Species 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
241001494479 Pecora Species 0.000 description 2
108020005067 RNA Splice Sites Proteins 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
239000000370 acceptor Substances 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
229960003677 chloroquine Drugs 0.000 description 2
WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
210000003013 erythroid precursor cell Anatomy 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
235000003642 hunger Nutrition 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
229960004452 methionine Drugs 0.000 description 2
244000005700 microbiome Species 0.000 description 2
238000002156 mixing Methods 0.000 description 2
125000000896 monocarboxylic acid group Chemical group 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
239000008194 pharmaceutical composition Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
239000002994 raw material Substances 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000006748 scratching Methods 0.000 description 2
230000002393 scratching effect Effects 0.000 description 2
239000012679 serum free medium Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
230000002485 urinary effect Effects 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
XPBVBZPVNFIHOA-UVBJJODRSA-N Ala-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 XPBVBZPVNFIHOA-UVBJJODRSA-N 0.000 description 1
241001203868 Autographa californica Species 0.000 description 1
108010028006 B-Cell Activating Factor Proteins 0.000 description 1
108010077805 Bacterial Proteins Proteins 0.000 description 1
101100328086 Caenorhabditis elegans cla-1 gene Proteins 0.000 description 1
241000282552 Chlorocebus aethiops Species 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108050009160 DNA polymerase 1 Proteins 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241001131785 Escherichia coli HB101 Species 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
102000003996 Interferon-beta Human genes 0.000 description 1
108090000467 Interferon-beta Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
230000004988 N-glycosylation Effects 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
101800000135 N-terminal protein Proteins 0.000 description 1
MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
206010058116 Nephrogenic anaemia Diseases 0.000 description 1
102000005348 Neuraminidase Human genes 0.000 description 1
108010006232 Neuraminidase Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
101800001452 P1 proteinase Proteins 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
101710182490 Protein oar Proteins 0.000 description 1
244000305267 Quercus macrolepis Species 0.000 description 1
208000035415 Reinfection Diseases 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
101710185500 Small t antigen Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
241000256251 Spodoptera frugiperda Species 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000003277 amino acid sequence analysis Methods 0.000 description 1
230000003321 amplification Effects 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
238000010170 biological method Methods 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
239000012876 carrier material Substances 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
208000020832 chronic kidney disease Diseases 0.000 description 1
208000022831 chronic renal failure syndrome Diseases 0.000 description 1
238000010367 cloning Methods 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000012091 fetal bovine serum Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000001879 gelation Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
238000012606 in vitro cell culture Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
210000003000 inclusion body Anatomy 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
239000003999 initiator Substances 0.000 description 1
230000026045 iodination Effects 0.000 description 1
238000006192 iodination reaction Methods 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
239000006166 lysate Substances 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
150000002741 methionine derivatives Chemical class 0.000 description 1
238000004452 microanalysis Methods 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
102000042567 non-coding RNA Human genes 0.000 description 1
210000003924 normoblast Anatomy 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 1
229940067157 phenylhydrazine Drugs 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000007026 protein scission Effects 0.000 description 1
238000000734 protein sequencing Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
239000000700 radioactive tracer Substances 0.000 description 1
230000006798 recombination Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
230000003014 reinforcing effect Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
238000002390 rotary evaporation Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000002356 single layer Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
238000003892 spreading Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000004575 stone Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Classifications

- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DD87310862A 1985-01-22 1987-12-06 Verfahren zur herstellung von erythropoietin DD279687A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US69325885A	1985-01-22	1985-01-22

Publications (1)

Publication Number	Publication Date
DD279687A5 true DD279687A5 (de)	1990-06-13

Family

ID=24783958

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD87310862A DD279687A5 (de)	1985-01-22	1987-12-06	Verfahren zur herstellung von erythropoietin

Country Status (4)

Country	Link
DD (1)	DD279687A5 (ro)
MD (1)	MD95C2 (ro)
RU (1)	RU1801118C (ro)
UA (1)	UA19039A (ro)

1985
- 1985-12-03 UA UA4203324A patent/UA19039A/uk unknown
1987
- 1987-09-09 RU SU874203324A patent/RU1801118C/ru active
- 1987-12-06 DD DD87310862A patent/DD279687A5/de unknown
1994
- 1994-02-09 MD MD94-0104A patent/MD95C2/ro active IP Right Grant

Also Published As

Publication number	Publication date
MD95B1 (ro)	1994-11-30
MD95C2 (ro)	1995-03-31
RU1801118C (ru)	1993-03-07
UA19039A (uk)	1997-12-25

Legal Events

Date	Code	Title	Description
2004-04-28	IF04	In force in the year 2004	Expiry date: 20051207

Publication	Publication Date	Title
DE68916537T2 (de)	1995-01-19	Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
EP0409113B1 (de)	1996-06-12	Muteine des menschlichen Erythropoetins, ihre Herstellung und ihre Verwendung
DE69033301T2 (de)	2000-04-20	Erythropoietin- Analoge
DE3880922T2 (de)	1993-08-26	Faktor viii-analog, verfahren zu dessen herstellung und dieses enthaltende zusammensetzung.
DE69034171T2 (de)	2006-02-02	Rekombinanter Proteaseinhibitor des Alzheimer-Amyloid-Proteins
DE69032600T3 (de)	2006-07-20	Rekombinanter abkömmling des menschlichen faktors iii
DE3650774T2 (de)	2003-05-28	Rekombinante Fibroblasten-Wachstums-Faktoren
EP0205564B2 (en)	2000-06-21	Method for the production of erythropoietin
DE69230206T2 (de)	2000-05-18	Rekombinante derivate des menschlichen faktors viii
DE69020335T2 (de)	1995-11-02	B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
DE68928718T2 (de)	1998-10-29	Human-Nervenwachstumsfaktor
RU2129613C1 (ru)	1999-04-27	Способ получения эритропоэтина человека
DD251788A5 (de)	1987-11-25	Verfahren zur Herstellung eines menschlichen cDNA-Klons
DE69230561T2 (de)	2000-08-10	Aus t-lymphozyten gewonnener hämatopoietischer wachstumsfaktor und verfahren zu seiner verwendung
DD257271A1 (de)	1988-06-08	Verfahren zur herstellung von menschlichem wachstumshormon (somatotropin)
AU5711199A (en)	2000-01-13	Method for the production of erythropoietin
DD251786A5 (de)	1987-11-25	Verfahren zur Herstellung eines Polypeptids
DD255359A5 (de)	1988-03-30	Verfahren zur bestimmung eines spezifischen einzelstraengigen polynuclebtids unbekannter sequenz